<?xml version="1.0" encoding="utf-8"?>
<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:hal="http://hal.archives-ouvertes.fr/" xmlns:gml="http://www.opengis.net/gml/3.3/" xmlns:gmlce="http://www.opengis.net/gml/3.3/ce" version="1.1" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 http://api.archives-ouvertes.fr/documents/aofr-sword.xsd">
  <teiHeader>
    <fileDesc>
      <titleStmt>
        <title>HAL TEI export of hal-03172552</title>
      </titleStmt>
      <publicationStmt>
        <distributor>CCSD</distributor>
        <availability status="restricted">
          <licence target="https://creativecommons.org/publicdomain/zero/1.0/">CC0 1.0 - Universal</licence>
        </availability>
        <date when="2026-05-13T10:52:12+02:00"/>
      </publicationStmt>
      <sourceDesc>
        <p part="N">HAL API Platform</p>
      </sourceDesc>
    </fileDesc>
  </teiHeader>
  <text>
    <body>
      <listBibl>
        <biblFull>
          <titleStmt>
            <title xml:lang="en">Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3</title>
            <author role="aut">
              <persName>
                <forename type="first">I.</forename>
                <surname>Borget</surname>
              </persName>
              <idno type="halauthorid">560990-0</idno>
              <affiliation ref="#struct-59772"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">J.</forename>
                <surname>Cadranel</surname>
              </persName>
              <idno type="halauthorid">489892-0</idno>
              <affiliation ref="#struct-523218"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">J.-P.</forename>
                <surname>Pignon</surname>
              </persName>
              <email type="md5">9771f7c5d5264ecd43609bf14e5770ae</email>
              <email type="domain">gustaveroussy.fr</email>
              <idno type="idhal" notation="numeric">998901</idno>
              <idno type="halauthorid" notation="string">1115370-998901</idno>
              <affiliation ref="#struct-106188"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">E.</forename>
                <surname>Quoix</surname>
              </persName>
              <idno type="halauthorid">467234-0</idno>
              <affiliation ref="#struct-300149"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">B.</forename>
                <surname>Coudert</surname>
              </persName>
              <idno type="halauthorid">830806-0</idno>
              <affiliation ref="#struct-139528"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">V.</forename>
                <surname>Westeel</surname>
              </persName>
              <idno type="halauthorid">367154-0</idno>
              <affiliation ref="#struct-111518"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">E.</forename>
                <surname>Dansin</surname>
              </persName>
              <idno type="halauthorid">625885-0</idno>
              <affiliation ref="#struct-301886"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">J.</forename>
                <surname>Madelaine</surname>
              </persName>
              <idno type="halauthorid">146136-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">A.</forename>
                <surname>Madroszyk</surname>
              </persName>
              <idno type="halauthorid">490962-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">S.</forename>
                <surname>Friard</surname>
              </persName>
              <idno type="halauthorid">467233-0</idno>
              <affiliation ref="#struct-410109"/>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">C.</forename>
                <surname>Daniel</surname>
              </persName>
              <idno type="halauthorid">109156-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">F.</forename>
                <surname>Morin</surname>
              </persName>
              <idno type="halauthorid">127887-0</idno>
            </author>
            <author role="aut">
              <persName>
                <forename type="first">C.</forename>
                <surname>Chouaid</surname>
              </persName>
              <idno type="halauthorid">560913-0</idno>
            </author>
            <editor role="depositor">
              <persName>
                <forename>Jean-Luc</forename>
                <surname>Prétet</surname>
              </persName>
              <email type="md5">aeee860b752a5893836894da55d74a01</email>
              <email type="domain">univ-fcomte.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>
            <edition n="v1" type="current">
              <date type="whenSubmitted">2021-03-17 17:47:50</date>
              <date type="whenModified">2026-05-13 03:13:36</date>
              <date type="whenReleased">2021-03-17 17:47:50</date>
              <date type="whenProduced">2011-12-31</date>
              <ref type="externalLink" target="http://erj.ersjournals.com/content/39/1/172.full.pdf"/>
            </edition>
            <respStmt>
              <resp>contributor</resp>
              <name key="151527">
                <persName>
                  <forename>Jean-Luc</forename>
                  <surname>Prétet</surname>
                </persName>
                <email type="md5">aeee860b752a5893836894da55d74a01</email>
                <email type="domain">univ-fcomte.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>
            <distributor>CCSD</distributor>
            <idno type="halId">hal-03172552</idno>
            <idno type="halUri">https://hal.science/hal-03172552</idno>
            <idno type="halBibtex">borget:hal-03172552</idno>
            <idno type="halRefHtml">&lt;i&gt;European Respiratory Journal&lt;/i&gt;, 2011, 39 (1), pp.172-179. &lt;a target="_blank" href="https://dx.doi.org/10.1183/09031936.00201210"&gt;&amp;#x27E8;10.1183/09031936.00201210&amp;#x27E9;&lt;/a&gt;</idno>
            <idno type="halRef">European Respiratory Journal, 2011, 39 (1), pp.172-179. &amp;#x27E8;10.1183/09031936.00201210&amp;#x27E9;</idno>
            <availability status="restricted"/>
          </publicationStmt>
          <seriesStmt>
            <idno type="stamp" n="UNIV-PSUD">Université Paris Sud - Paris XI</idno>
            <idno type="stamp" n="APHP" corresp="INSERM">AP-HP</idno>
            <idno type="stamp" n="CESP" corresp="INSERM">Centre de recherche en Épidémiologie et Santé des Populations</idno>
            <idno type="stamp" n="FNCLCC" corresp="INSERM">UNICANCER</idno>
            <idno type="stamp" n="CGFL" corresp="FNCLCC">Centre Georges Francois Leclerc</idno>
            <idno type="stamp" n="IGR" corresp="FNCLCC">Institut Gustave Roussy</idno>
            <idno type="stamp" n="LAMBRET" corresp="INSERM">Centre Oscar Lambret</idno>
            <idno type="stamp" n="UVSQ">Université de Versailles Saint-Quentin-en-Yvelines</idno>
            <idno type="stamp" n="UNIV-PARIS-SACLAY">Université Paris-Saclay</idno>
            <idno type="stamp" n="UNIV-PSUD-SACLAY" corresp="UNIV-PARIS-SACLAY">Université Paris Sud pour Paris Saclay</idno>
            <idno type="stamp" n="UNIV-LILLE">Université de Lille</idno>
            <idno type="stamp" n="GS-SANTE-PUBLIQUE">Graduate School Santé publique</idno>
            <idno type="stamp" n="TEST3-HALCNRS">TEST3-HALCNRS</idno>
          </seriesStmt>
          <notesStmt>
            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>
            <biblStruct>
              <analytic>
                <title xml:lang="en">Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3</title>
                <author role="aut">
                  <persName>
                    <forename type="first">I.</forename>
                    <surname>Borget</surname>
                  </persName>
                  <idno type="halauthorid">560990-0</idno>
                  <affiliation ref="#struct-59772"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">J.</forename>
                    <surname>Cadranel</surname>
                  </persName>
                  <idno type="halauthorid">489892-0</idno>
                  <affiliation ref="#struct-523218"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">J.-P.</forename>
                    <surname>Pignon</surname>
                  </persName>
                  <email type="md5">9771f7c5d5264ecd43609bf14e5770ae</email>
                  <email type="domain">gustaveroussy.fr</email>
                  <idno type="idhal" notation="numeric">998901</idno>
                  <idno type="halauthorid" notation="string">1115370-998901</idno>
                  <affiliation ref="#struct-106188"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">E.</forename>
                    <surname>Quoix</surname>
                  </persName>
                  <idno type="halauthorid">467234-0</idno>
                  <affiliation ref="#struct-300149"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">B.</forename>
                    <surname>Coudert</surname>
                  </persName>
                  <idno type="halauthorid">830806-0</idno>
                  <affiliation ref="#struct-139528"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">V.</forename>
                    <surname>Westeel</surname>
                  </persName>
                  <idno type="halauthorid">367154-0</idno>
                  <affiliation ref="#struct-111518"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">E.</forename>
                    <surname>Dansin</surname>
                  </persName>
                  <idno type="halauthorid">625885-0</idno>
                  <affiliation ref="#struct-301886"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">J.</forename>
                    <surname>Madelaine</surname>
                  </persName>
                  <idno type="halauthorid">146136-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">A.</forename>
                    <surname>Madroszyk</surname>
                  </persName>
                  <idno type="halauthorid">490962-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">S.</forename>
                    <surname>Friard</surname>
                  </persName>
                  <idno type="halauthorid">467233-0</idno>
                  <affiliation ref="#struct-410109"/>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">C.</forename>
                    <surname>Daniel</surname>
                  </persName>
                  <idno type="halauthorid">109156-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">F.</forename>
                    <surname>Morin</surname>
                  </persName>
                  <idno type="halauthorid">127887-0</idno>
                </author>
                <author role="aut">
                  <persName>
                    <forename type="first">C.</forename>
                    <surname>Chouaid</surname>
                  </persName>
                  <idno type="halauthorid">560913-0</idno>
                </author>
              </analytic>
              <monogr>
                <idno type="halJournalId" status="VALID">13128</idno>
                <idno type="issn">0903-1936</idno>
                <idno type="eissn">1399-3003</idno>
                <title level="j">European Respiratory Journal</title>
                <imprint>
                  <publisher>European Respiratory Society</publisher>
                  <biblScope unit="volume">39</biblScope>
                  <biblScope unit="issue">1</biblScope>
                  <biblScope unit="pp">172-179</biblScope>
                  <date type="datePub">2011-12-31</date>
                </imprint>
              </monogr>
              <idno type="doi">10.1183/09031936.00201210</idno>
              <idno type="pubmed">21659409</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>
            <langUsage>
              <language ident="en">English</language>
            </langUsage>
            <textClass>
              <classCode scheme="mesh">Aged</classCode>
              <classCode scheme="mesh">Carcinoma, Non-Small-Cell Lung</classCode>
              <classCode scheme="mesh">ErbB Receptors</classCode>
              <classCode scheme="mesh">Erlotinib Hydrochloride</classCode>
              <classCode scheme="mesh">Female</classCode>
              <classCode scheme="mesh">Humans</classCode>
              <classCode scheme="mesh">Lung Neoplasms</classCode>
              <classCode scheme="mesh">Male</classCode>
              <classCode scheme="mesh">Markov Chains</classCode>
              <classCode scheme="mesh">Medical Oncology</classCode>
              <classCode scheme="mesh">Middle Aged</classCode>
              <classCode scheme="mesh">Mutation</classCode>
              <classCode scheme="mesh">Protein Kinase Inhibitors</classCode>
              <classCode scheme="mesh">Quality of Life</classCode>
              <classCode scheme="mesh">Quinazolines</classCode>
              <classCode scheme="mesh">Sensitivity and Specificity</classCode>
              <classCode scheme="mesh">Cost-Benefit Analysis</classCode>
              <classCode scheme="halDomain" n="sdv.can">Life Sciences [q-bio]/Cancer</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halOldTypology" n="ART">Journal articles</classCode>
              <classCode scheme="halTreeTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">
              <p>Several clinical and biological parameters are known to influence the efficacy of second-line erlotinib therapy for nonsmall cell lung cancer (NSCLC), but their medico-economic impact has not been evaluated. The objective of this study was to compare the incremental cost-effectiveness ratios of strategies for second-line erlotinib initiation in NSCLC: clinically guided initiation (nonsmoking females with adenocarcinoma received erlotinib; all other patients received docetaxel) and biologically guided selection (patients with epidermal growth factor receptor (EGFR) mutation received erlotinib; patients with wild-type EGFR or unknown status received docetaxel), compared with initiation with no patient selection (strategy reference). A Markov model was constructed. Outcomes (overall and progression-free survival), transition probabilities and direct medical costs (from the French third-party payer's perspective) were prospectively collected for individual patients treated with either erlotinib or docetaxel, from treatment initiation to disease progression. Published data were used to estimate utilities and post-progression costs. Sensitivity analyses were performed. The biologically and clinically guided strategies were both more efficient (incremental quality-adjusted life-yrs equal to 0.080 and 0.081, respectively) and less expensive (cost decrease equal to €5,020 and €5,815, respectively) than the no-selection strategy, and the biologically guided strategy was slightly less expensive than the clinically guided strategy. Sensitivity analyses confirmed the robustness of the results. The cost-effectiveness of second-line NSCLC treatment is improved when patients are selected on either clinical or biological grounds.</p>
            </abstract>
          </profileDesc>
        </biblFull>
      </listBibl>
    </body>
    <back>
      <listOrg type="structures">
        <org type="department" xml:id="struct-59772" status="VALID">
          <orgName>Service de biostatistique et d'épidémiologie</orgName>
          <orgName type="acronym">SBE</orgName>
          <desc>
            <address>
              <addrLine>Gustave Roussy. 114, rue Édouard-Vaillant. 94805 Villejuif Cedex - France</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-456659" type="direct"/>
            <relation active="#struct-156104" type="indirect"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-523218" status="INCOMING">
          <orgName>Centre de compétences pour les maladies pulmonaires rares</orgName>
          <desc>
            <address>
              <addrLine>Paris</addrLine>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-106188" status="OLD">
          <idno type="IdRef">156182254</idno>
          <idno type="ISNI">0000 0004 0638 6872 </idno>
          <idno type="RNSR">201019083D</idno>
          <idno type="ROR">https://ror.org/01ed4t417</idno>
          <orgName>Centre de recherche en épidémiologie et santé des populations</orgName>
          <orgName type="acronym">CESP</orgName>
          <date type="end">2019-12-31</date>
          <desc>
            <address>
              <addrLine>16 avenue Paul Vaillant Couturier 94807 Villejuif Cedex, France</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation name="UMR U1018" active="#struct-81173" type="direct"/>
            <relation active="#struct-92966" type="direct"/>
            <relation active="#struct-300068" type="direct"/>
            <relation active="#struct-300153" type="direct"/>
            <relation active="#struct-1066727" type="indirect"/>
            <relation name="U1018" active="#struct-303623" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-300149" status="VALID">
          <orgName>Centre Hospitalier Universitaire [Strasbourg]</orgName>
          <orgName type="acronym">CHU Strasbourg</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.chru-strasbourg.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-211628" type="direct"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-139528" status="VALID">
          <orgName>Département de Biologie et pathologie des tumeurs [Centre Georges-François Leclerc]</orgName>
          <desc>
            <address>
              <addrLine>1 Rue du Professeur Marion, 21000 Dijon</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.cgfl.fr/infos-pratiques/lannuaire-des-equipes/par-service.html</ref>
          </desc>
          <listRelation>
            <relation active="#struct-301099" type="direct"/>
            <relation active="#struct-502406" type="indirect"/>
          </listRelation>
        </org>
        <org type="laboratory" xml:id="struct-111518" status="VALID">
          <idno type="IdRef">166217115</idno>
          <idno type="RNSR">200014480U</idno>
          <orgName>Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (UR 3181)</orgName>
          <orgName type="acronym">CEF2P / CARCINO</orgName>
          <desc>
            <address>
              <addrLine>Les hauts de chazal - bât. Recherche - rue Ambroise Paré - 25000 BESANCON</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.univ-fcomte.fr/pages/fr/menu1/recherche/la-recherche-a-l-ufc/ea-3181---carcinogenese-18229-8079.html</ref>
          </desc>
          <listRelation>
            <relation name="UR 3181" active="#struct-300165" type="direct"/>
            <relation name="EA3181" active="#struct-458810" type="direct"/>
            <relation active="#struct-426438" type="indirect"/>
          </listRelation>
        </org>
        <org type="regrouplaboratory" xml:id="struct-301886" status="VALID">
          <idno type="ISNI">0000 0001 0131 6312</idno>
          <idno type="ROR">https://ror.org/03xfq7a50</idno>
          <orgName>Centre Régional de Lutte contre le Cancer Oscar Lambret [Lille]</orgName>
          <orgName type="acronym">UNICANCER/Lille</orgName>
          <desc>
            <address>
              <addrLine>3, rue Frédéric Combemale, 59020 Lille</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.centreoscarlambret.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-374570" type="direct"/>
            <relation active="#struct-502406" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-410109" status="VALID">
          <idno type="ROR">https://ror.org/058td2q88</idno>
          <orgName>Hôpital Foch [Suresnes]</orgName>
          <desc>
            <address>
              <addrLine>40 Rue Worth 92150 Suresnes</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.hopital-foch.com/</ref>
          </desc>
        </org>
        <org type="laboratory" xml:id="struct-456659" status="VALID">
          <orgName>Direction de la recherche clinique [Gustave Roussy]</orgName>
          <desc>
            <address>
              <addrLine>Gustave Roussy. 114, rue Édouard-Vaillant 94805 Villejuif Cedex -France</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-156104" type="direct"/>
          </listRelation>
        </org>
        <org type="institution" xml:id="struct-156104" status="VALID">
          <idno type="IdRef">026387433</idno>
          <idno type="ROR">https://ror.org/0321g0743</idno>
          <orgName>Institut Gustave Roussy</orgName>
          <orgName type="acronym">IGR</orgName>
          <desc>
            <address>
              <addrLine>114, rue Édouard-Vaillant 94805 Villejuif Cedex -France</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.gustaveroussy.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-81173" status="VALID">
          <idno type="IdRef">03082057X</idno>
          <idno type="ISNI">0000 0001 2323 0229 </idno>
          <idno type="ROR">https://ror.org/03mkjjy25</idno>
          <orgName>Université de Versailles Saint-Quentin-en-Yvelines</orgName>
          <orgName type="acronym">UVSQ</orgName>
          <date type="start">1991-07-22</date>
          <desc>
            <address>
              <addrLine>55 avenue de Paris - 78035 Versailles cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.uvsq.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-92966" status="OLD">
          <idno type="ROR">https://ror.org/028rypz17</idno>
          <orgName>Université Paris-Sud - Paris 11</orgName>
          <orgName type="acronym">UP11</orgName>
          <date type="end">2019-12-31</date>
          <desc>
            <address>
              <addrLine>Bâtiment 300 - 91405 Orsay cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.u-psud.fr/</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-300068" status="VALID">
          <idno type="ROR">https://ror.org/00pg5jh14</idno>
          <orgName>Assistance publique - Hôpitaux de Paris (AP-HP)</orgName>
          <orgName type="acronym">AP-HP</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
          </desc>
        </org>
        <org type="institution" xml:id="struct-300153" status="VALID">
          <idno type="ROR">https://ror.org/05n7yzd13</idno>
          <orgName>Hôpital Paul Brousse</orgName>
          <desc>
            <address>
              <addrLine>12 Avenue Paul Vaillant Couturier, 94800 Villejuif</addrLine>
              <country key="FR"/>
            </address>
          </desc>
          <listRelation>
            <relation active="#struct-1066727" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-1066727" status="VALID">
          <orgName>AP-HP. Université Paris Saclay</orgName>
          <desc>
            <address>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.aphp.fr/groupes-hospitaliers-de-lap-hp</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-303623" status="VALID">
          <idno type="IdRef">026388278</idno>
          <idno type="ROR">https://ror.org/02vjkv261</idno>
          <orgName>Institut National de la Santé et de la Recherche Médicale</orgName>
          <orgName type="acronym">INSERM</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75013 Paris</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.inserm.fr</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-211628" status="VALID">
          <idno type="IdRef">030378842</idno>
          <idno type="ROR">https://ror.org/04bckew43</idno>
          <orgName>Hôpitaux Universitaires de Strasbourg</orgName>
          <orgName type="acronym">HUS</orgName>
          <desc>
            <address>
              <addrLine>1 place de l'hôpital BP 426 67091 Strasbourg cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.chru-strasbourg.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-301099" status="VALID">
          <idno type="ISNI">0000 0004 0641 1257</idno>
          <idno type="ROR">https://ror.org/00pjqzf38</idno>
          <orgName>Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon]</orgName>
          <orgName type="acronym">UNICANCER/CRLCC-CGFL</orgName>
          <desc>
            <address>
              <addrLine>1 Rue du Professeur Marion, 21000 Dijon</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.cgfl.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-502406" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-502406" status="VALID">
          <orgName>UNICANCER</orgName>
          <desc>
            <address>
              <addrLine>101, rue de Tolbiac, 75654 Paris Cedex 13</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.unicancer.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-300165" status="VALID">
          <orgName>Centre Hospitalier Régional Universitaire de Besançon</orgName>
          <orgName type="acronym">CHRU Besançon</orgName>
          <desc>
            <address>
              <addrLine>3, boulevard A. Fleming - 25030 Besançon Cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.chu-besancon.fr/</ref>
          </desc>
        </org>
        <org type="institution" xml:id="struct-458810" status="VALID">
          <idno type="IdRef">026403188</idno>
          <idno type="ISNI">0000000121883779</idno>
          <idno type="ROR">https://ror.org/03pcc9z86</idno>
          <orgName>Université Marie et Louis Pasteur</orgName>
          <orgName type="acronym">UMLP</orgName>
          <desc>
            <address>
              <addrLine>1 rue Goudimel25030 Besançon cedex</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.umlp.fr/</ref>
          </desc>
          <listRelation>
            <relation active="#struct-426438" type="direct"/>
          </listRelation>
        </org>
        <org type="regroupinstitution" xml:id="struct-426438" status="VALID">
          <idno type="IdRef">200716271</idno>
          <idno type="ISNI">0000 0004 4910 6615</idno>
          <idno type="ROR">https://ror.org/02dn7x778</idno>
          <orgName>Université Bourgogne Franche-Comté [COMUE]</orgName>
          <orgName type="acronym">UBFC</orgName>
          <date type="start">2015-04-01</date>
          <date type="end">2024-12-31</date>
          <desc>
            <address>
              <addrLine>32, avenue de l’observatoire25000 BESANCON</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">http://www.ubfc.fr</ref>
          </desc>
        </org>
        <org type="regroupinstitution" xml:id="struct-374570" status="VALID">
          <idno type="IdRef">223446556</idno>
          <idno type="ISNI">0000 0001 2242 6780</idno>
          <idno type="ROR">https://ror.org/02kzqn938</idno>
          <idno type="Wikidata">Q3551621</idno>
          <orgName>Université de Lille</orgName>
          <desc>
            <address>
              <addrLine>EPE Université de Lille. -- 42 rue Paul Duez, 59000 Lille</addrLine>
              <country key="FR"/>
            </address>
            <ref type="url">https://www.univ-lille.fr/</ref>
          </desc>
        </org>
      </listOrg>
    </back>
  </text>
</TEI>